Table 1.

Demographics and neuropsychological assessment of SCD and MCI subjects.

	SCD (n = 14)			MCI (n = 16)
	T0	T2	p	T0	T2	p
Age	67.21 ± 6.90	67.21 ± 6.90	–	65.94 ± 7.03	65.94 ± 7.03	–
Female	11	11	–	14	14	–
Education	11.75 ± 2.94	11.75 ± 2.94	–	12.5 ± 2.76	12.5 ± 2.76	–
MMSE	28.29 ± 1.44	28.43 ± 1.29	0.655	27.69 ± 1.40	28.13 ± 1.17	0.387
MOCA	25.57 ± 1.84	25.79 ± 2.40	0.732	23.88 ± 2.23	24.81 ± 3.68	0.243
CDR	0.43 ± 0.18	0.36 ± 0.23	0.1665	0.38 ± 0.22	0.28 ± 0.26	0.333
AVLT-20-min DR	5.71 ± 2.68	7.29 ± 2.60	0.049*	4.56 ± 3.00	7.25 ± 2.63	0.001*
LMT-20-min DR	3.86 ± 2.61	5.79 ± 3.95	0.182	4.00 ± 2.87	5.25 ± 2.63	0.159
CFT-20-min DR	18.79 ± 4.23	20.07 ± 6.43	0.450	10.44 ± 6.37	18.19 ± 7.38	0.001**
VFT	20.5 ± 3.64	21.64 ± 4.42	0.411	25.19 ± 28.08	18.19 ± 2.94	0.373
DST-backward	12.79 ± 1.37	13.43 ± 3.20	0.456	11.25 ± 1.30	12.13 ± 1.65	0.074
DSST	39.8 ± 10.19	43.21 ± 14.19	0.186	32.44 ± 6.37	38.06 ± 9.74	0.032*
TMT-A	52.64 ± 10.74	56.43 ± 16.71	0.321	64.06 ± 18.71	58.06 ± 13.80	0.074
CFT	35.36 ± 1.59	35.36 ± 1.11	1.000	32.56 ± 3.94	34.25 ± 1.92	0.041*
CDT	9.29 ± 0.96	9.07 ± 0.70	0.385	9.13 ± 0.93	9.25 ± 0.66	0.652
HAMD	4.36 ± 4.05	3.14 ± 3.81	0.405	3.44 ± 2.34	12.00 ± 1.73	0.012*
HAMA	5.43 ± 6.04	4.71 ± 4.60	0.609	4.00 ± 2.03	1.75 ± 1.35	0.002*
SCD-Q	6.29 ± 0.84	6.07 ± 1.10	0.481	5.72 ± 1.29	5.38 ± 1.52	0.127

Numbers are given as means (standard deviation, SD) unless stated otherwise. Paired t-tests were used to test for statistical differences between groups before and after the TMS intervention. *showed a significantly group difference between T0 and T2, p < 0.05; SCD, subjective cognitive decline; MCI, mild cognitive impairment.